Member Info for Rockefellow

Up in a straight line since 2pm US buying /UBS

I’ve emailed UBS.nothing .Investor relations ..nothing.Stock cannot move forward with good research .I the meantime we have Peel 508p and Jefferies 455p

Peel Hunt 508p.Jefferies 455p.UBS still adding up.

Ingredients remain

2 new projects being worked on .one pulmonary one CNS .both massive market opportunities .will announce when ready

Must be imminent

Trial will take a year.A Karuna style royalty deal is likely .selling non US rights also likely.several billion pa potential.two new projects almost ready to be announced.

At year end $365m plus 37pc of Seaports $325m cash.ie $485m

$19m was paid from Royalty Pharma and $10m from Karuna on FDA approval.Royalty are getting their 3pc on any sales now.The remaining $381m is paid in tranches as sales thresholds are reached. as we rise to $2bn.Terms are normally confidential.Above $2bn terms are clear.

Https://news.puretechhealth.com/node/14581/pdf

I never got a reply too.Its pathetic.Where is UBS?

Https://news.puretechhealth.com/node/14581/pdf

Will be an opportunity to discuss why LYT100 will become the Standard of Care for IPF generating several billion dollars per annum in due course.

Puretech is talking billions of revenues for LYT100 in years to come

Https://puretechhealth.com/images/PRTCCorpPresentation.pdf

$365m cash at year end.

No point in switching from Jefferies to UBS unless they were going to take Puretech seriously.

The ingredients are there.

Https://www.plc-awards.co.uk/

A multibillion dollar opportunity according to the latest presentation .cant be more positive than that!

Sector is in free fall atm..UBS can make a difference.If LYT100 really does sell several billion dollars pa. That’s over $1bn profits pa implying a value of around $10bn for LYT100 alone.

LYT100 multibillion dollar potential

https://puretechhealth.com/images/PRTCCorpPresentation.pdf